Europe

Mon
02
Mar

Global Drug Law Monitor Hints At Fresh Approach To Cannabis Regulation

The International Narcotics Control Board (INCB), responsible for monitoring compliance with global drug treaties, has admitted it may have to water down its hardline approach to cannabis regulation to stay relevant.

Fri
28
Feb

Here Are The Changes Needed For International Cannabis Legalization

It took twelve months of research, investigations, and interviews (and about five weeks of non-stop writing with some very late nights and a lot of coffee) to produce my book on cannabis law and regulation, which is out now with Bloomsbury Professional. It is a detailed analysis of medicinal and recreational cannabis laws and regulations in the most active international jurisdictions, scoping out where change is happening.

Wed
26
Feb

CBD market on course to grow 400% in Europe alone

Over the next five years, the global CBD market is expected to accelerate to $23.6bn, according to Grand View Research and Europe’s CBD market is set to grow by 400%.

The growth of the CBD market in Europe is thanks to the growing adoption of CBD infused products in industries such as pharmaceuticals, personal care, cosmetics, nutraceuticals, along with medical applications.

Tue
25
Feb

CBD in Europe report: making the single market real

Pan-European Association, ACTIVE has launched its first English-speaking report: CBD in Europe — Making the Single Market Real.

The report is the second ACTIVE report, and provides a detailed look at the most recent developments occurring inside the nascent European CBD industry.

Fri
21
Feb

Is Europe the Next Big Market for Pot Stocks?

Investing in pot stocks has changed dramatically in the few years that the industry has been around. This is a mixture of legislative changes and the shift in how the public views marijuana as a substance. Right now, the U.S. and Canada are the main focal points of the cannabis industry. This is because of the laws that exist that have helped to push the cannabis industry forward. In Canada, marijuana has been fully legal for around two years. The Canadian cannabis industry has its fair share of challenges, but the expectations for the future remain high.

Thu
20
Feb

3 Major European Cannabis Markets Investors Need To Be Watching

During the last year, we have seen a significant shift in the cannabis sector to where the market is considerably more focused on the international opportunity. Although Canada remains a great opportunity, the market is saturated, and distribution is limited. For this reason, we have seen a significant increase in the number of companies that are focused on the cannabis market in the European Union (EU).

With a population that is twice the size of the US, we are bullish on the cannabis opportunity in the EU and believe that this will be the next frontier of growth for the industry. Today, we have highlighted 3 companies that are focused on a number of markets in the EU and believe that these are opportunities to have on your radar.

Thu
13
Feb

Ban On Natural CBD In European Cosmetics Lifted In Victory For ‘Common Sense’

The lifting of a ban on the use of CBD in creams and cosmetics will be a major boost for smaller European businesses.

In early 2019 the European Commission (E.C.) introduced new non-legally binding provisions which outlawed the use of natural CBD in cosmetics in favour of synthetic CBD. However, the European Industrial Hemp Association (EIHA)  has successfully overturned the decision following an intensive lobbying campaign, led by its Managing Director Lorenza Romanese.

Tue
11
Feb

European Alliance for Medicinal Cannabis: representing licensed producers

‘Promoting a sensible policy towards medicinal cannabis in the EU27’: this is the mission of the European Alliance for Medicinal Cannabis (EAMC).

The European Alliance for Medicinal Cannabis (EAMC) is the Brussels-based, industry-led organisation representing medical cannabis licensed producers across the European Union.

On 9 February 2020, EAMC hosted a networking event with around +50 invited industry delegates, ahead of the Cannabis Europa conference in Madrid.

Mon
10
Feb

Will European Medical Cannabis Shift From Flowers To Oils?

European medical cannabis will shift from capricious flowers to quality oils as patients seek consistent and reliable medicines.

Some manufacturers looking to supply Europe with competitively-priced medical cannabis are preparing for this shift. And, one Colombian cultivator says such a switch would have major benefits  in the German market – Europe’s premier medical cannabis country.

Oliver Zugel is founder of Colombian cultivator FoliuMed which hopes to have its first medical cannabis oils available for shipment to Europe by the end of the year.

Wed
05
Feb

European cannabis testing market expected to reach $807.9m by 2025

The European cannabis testing market is estimated to grow with a CAGR of 10.8% from 2018-2025.

The growth of the cannabis testing market is primarily attributed to the European government funding cannabis education for doctors, and the increasing demand for research activities for cannabis quality.

Pages

Subscribe to RSS - Europe